COURIER HEALTH RAISES $50M SERIES B FOR AI BIOPHARMA PLATFORM

The funding round included participation from Norwest Venture Partners. Courier Health's platform addresses a critical gap in drug development and patient management by automating and optimizing the complete patient journey from prescription through treatment completion. The company focuses on medication adherence and patient experience management, areas where pharmaceutical companies traditionally struggle. By leveraging AI, Courier Health streamlines workflows that typically involve multiple disconnected systems and manual processes. This Series B round brings total funding to the company and validates the growing market demand for digital health solutions in the biopharma sector. The capital will likely support product expansion and go-to-market initiatives as healthcare companies increasingly prioritize patient experience metrics alongside clinical outcomes. Courier Health joins a wave of startups modernizing pharmaceutical operations through automation and data analytics.